Wu-Ming Qin

716 total citations · 1 hit paper
13 papers, 571 citations indexed

About

Wu-Ming Qin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wu-Ming Qin has authored 13 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wu-Ming Qin's work include Cancer Mechanisms and Therapy (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sexual function and dysfunction studies (2 papers). Wu-Ming Qin is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sexual function and dysfunction studies (2 papers). Wu-Ming Qin collaborates with scholars based in China, Spain and Macao. Wu-Ming Qin's co-authors include Linghui Cao, Isaac Yaw Massey, Zhi Shi, Qiwei Jiang, Xiao-Long Mei, Youqiu Xue, Jian-Ge Qiu, Wenji Zhang, Meng-Ning Wei and Di-Wei Zheng and has published in prestigious journals such as Cancer Letters, Oncotarget and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Wu-Ming Qin

12 papers receiving 567 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of PI3K/Akt signaling pathway in cardiac fibrosis

2021 177 citations Wu-Ming Qin, Linghui Cao et al. Molecular and Cellular Biochemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wu-Ming Qin China	9	340	159	77	69	67	13	571
Wafaey Gomaa Saudi Arabia	14	192 0.6×	179 1.1×	71 0.9×	61 0.9×	105 1.6×	47	618
Weiwei Shao China	15	424 1.2×	112 0.7×	79 1.0×	165 2.4×	31 0.5×	38	675
C.-W. Chi Taiwan	17	240 0.7×	83 0.5×	69 0.9×	108 1.6×	50 0.7×	31	705
Zheng Wan China	17	280 0.8×	70 0.4×	96 1.2×	92 1.3×	66 1.0×	57	716
Yuting Wu China	14	351 1.0×	104 0.7×	113 1.5×	131 1.9×	20 0.3×	30	567
Yakun Yang China	15	192 0.6×	85 0.5×	45 0.6×	64 0.9×	37 0.6×	46	590
Huiyan Niu China	15	333 1.0×	95 0.6×	62 0.8×	93 1.3×	31 0.5×	26	505
Yunpeng Xie China	15	347 1.0×	99 0.6×	41 0.5×	99 1.4×	85 1.3×	43	574
Hongjiao Xiang China	13	285 0.8×	64 0.4×	42 0.5×	97 1.4×	28 0.4×	21	537

Countries citing papers authored by Wu-Ming Qin

Since Specialization

Citations

This map shows the geographic impact of Wu-Ming Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu-Ming Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu-Ming Qin more than expected).

Fields of papers citing papers by Wu-Ming Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu-Ming Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu-Ming Qin. The network helps show where Wu-Ming Qin may publish in the future.

Co-authorship network of co-authors of Wu-Ming Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wu-Ming Qin. A scholar is included among the top collaborators of Wu-Ming Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu-Ming Qin. Wu-Ming Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Qin, Wu-Ming, Xiaobo Yang, Shi Ouyang, et al.. (2025). Loss of lims1 causes aberrant cardiac remodeling and heart failure via activating gp130/Jak1/Stat3 pathway in zebrafish. Journal of genetics and genomics. 52(12). 1600–1611.

2.

Ouyang, Shi, Wu-Ming Qin, Yujuan Niu, Yonghe Ding, & Yun Deng. (2022). An EGFP Knock-in Zebrafish Experimental Model Used in Evaluation of the Amantadine Drug Safety During Early Cardiogenesis. Frontiers in Cardiovascular Medicine. 9. 839166–839166. 2 indexed citations

3.

Qin, Wu-Ming, Linghui Cao, & Isaac Yaw Massey. (2021). Role of PI3K/Akt signaling pathway in cardiac fibrosis. Molecular and Cellular Biochemistry. 476(11). 4045–4059. 177 indexed citations breakdown →

4.

Qin, Wu-Ming, Kun Wang, Jia-Rong Huang, Xiao-Long Mei, & Zhi Shi. (2018). Sildenafil Induces Cell Cycle Arrest and Apoptosis in Human Colorectal Cancer HT-29 Cells. 7(2). 59–63. 1 indexed citations

5.

Huang, Jia-Rong, Wu-Ming Qin, Kun Wang, et al.. (2018). Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo.. PubMed. 10(11). 3664–3676. 26 indexed citations

6.

Li, Yong, Meng-Ning Wei, Yao Chen, et al.. (2016). Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer. Cancer Letters. 386. 100–109. 31 indexed citations

7.

Lv, Min, Jian-Ge Qiu, Wenji Zhang, et al.. (2016). Wallichinine reverses ABCB1-mediated cancer multidrug resistance.. PubMed. 8(7). 2969–80. 12 indexed citations

8.

Qiu, Jian-Ge, Yaojun Zhang, Jinming Zhao, et al.. (2015). Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget. 6(17). 15494–15509. 61 indexed citations

9.

Jiang, Qiwei, Kejun Cheng, Xiao-Long Mei, et al.. (2015). Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget. 6(32). 32790–32804. 56 indexed citations

10.

Xue, Youqiu, Kejun Cheng, Jian-Ge Qiu, et al.. (2015). Antioxidant and Anticancer Activities of Raspberry Extracts. 4(2). 1 indexed citations

11.

Chen, Xiuxiu, Feng Lin, Jian-Ge Qiu, et al.. (2015). Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer. Oncotarget. 6(17). 14926–14939. 53 indexed citations

12.

Mei, Xiao-Long, Yang Yang, Yaojun Zhang, et al.. (2015). Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo.. PubMed. 5(11). 3311–24. 78 indexed citations

13.

Chen, Xiuxiu, Huan Wang, Qiwei Jiang, et al.. (2014). Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells. Oxidative Medicine and Cellular Longevity. 2014. 1–10. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact